These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 25597826)

  • 1. IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy.
    Wergeland I; Pullar N; Assmus J; Ueland T; Tonby K; Feruglio S; Kvale D; Damås JK; Aukrust P; Mollnes TE; Dyrhol-Riise AM
    J Infect; 2015 Apr; 70(4):381-91. PubMed ID: 25597826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects.
    Hur YG; Kang YA; Jang SH; Hong JY; Kim A; Lee SA; Kim Y; Cho SN
    J Infect; 2015 Apr; 70(4):346-55. PubMed ID: 25452040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.
    Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K
    Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection.
    Petrone L; Vanini V; Chiacchio T; Petruccioli E; Cuzzi G; Schininà V; Palmieri F; Ippolito G; Goletti D
    Tuberculosis (Edinb); 2018 Jul; 111():147-153. PubMed ID: 30029901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis.
    Tebruegge M; Dutta B; Donath S; Ritz N; Forbes B; Camacho-Badilla K; Clifford V; Zufferey C; Robins-Browne R; Hanekom W; Graham SM; Connell T; Curtis N
    Am J Respir Crit Care Med; 2015 Aug; 192(4):485-99. PubMed ID: 26030187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
    Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
    J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IP-10 is an accurate biomarker for the diagnosis of tuberculosis in children.
    Latorre I; Díaz J; Mialdea I; Serra-Vidal M; Altet N; Prat C; Díez N; Escribano A; Casas I; Rodrigo C; Ausina V; Ruhwald M; Domínguez J
    J Infect; 2014 Dec; 69(6):590-9. PubMed ID: 24975172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could inducible protein-10 and heparin-binding hemagglutinin improve the detection of Mycobacterium tuberculosis-infected subjects in a country with low incidence of tuberculosis?
    Molicotti P; Bua A; Cubeddu M; Ruggeri M; Mura MS; Pirina P; Zanetti S
    Infect Dis (Lond); 2015 Aug; 47(8):563-7. PubMed ID: 25856090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
    Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
    Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative biomarkers for classification of latent tuberculosis infection status in pregnant women with borderline Quantiferon plus results.
    Tesfaye F; Sturegård E; Walles J; Winqvist N; Balcha TT; Karlson S; Mulleta D; Isberg PE; Jansson M; Björkman P
    Tuberculosis (Edinb); 2020 Sep; 124():101984. PubMed ID: 32829076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country.
    Vanini V; Petruccioli E; Gioia C; Cuzzi G; Orchi N; Rianda A; Alba L; Giancola ML; Conte A; Schininà V; Rizzi EB; Girardi E; Goletti D
    J Infect; 2012 Jul; 65(1):49-59. PubMed ID: 22465752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of inducible protein 10 as a biomarker for the diagnosis of tuberculosis.
    Hong JY; Jung GS; Kim H; Kim YM; Lee HJ; Cho SN; Kim SK; Chang J; Kang YA
    Int J Infect Dis; 2012 Dec; 16(12):e855-9. PubMed ID: 22959355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Use of Interferon Gamma Inducible Protein 10 as a Potential Biomarker in the Diagnosis of Latent Tuberculosis Infection in Uganda.
    Biraro IA; Kimuda S; Egesa M; Cose S; Webb EL; Joloba M; Smith SG; Elliott AM; Dockrell HM; Katamba A
    PLoS One; 2016; 11(1):e0146098. PubMed ID: 26771653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of Interferon-Gamma and IP-10 Release Assays for Diagnosing Latent Tuberculosis Infections in Patients with Concurrent Malaria in Tanzania.
    Drabe CH; Vestergaard LS; Helleberg M; Nyagonde N; Rose MV; Francis F; Theilgaard OP; Asbjørn J; Amos B; Bygbjerg IC; Ruhwald M; Ravn P
    Am J Trop Med Hyg; 2016 Apr; 94(4):728-35. PubMed ID: 26834199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma cytokines and chemokines differentiate between active disease and non-active tuberculosis infection.
    Mihret A; Bekele Y; Bobosha K; Kidd M; Aseffa A; Howe R; Walzl G
    J Infect; 2013 Apr; 66(4):357-65. PubMed ID: 23178506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production.
    Jeong YH; Hur YG; Lee H; Kim S; Cho JE; Chang J; Shin SJ; Lee H; Kang YA; Cho SN; Ha SJ
    J Clin Microbiol; 2015 Feb; 53(2):504-10. PubMed ID: 25428147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of interferon gamma-inducible protein-10 and interferon gamma-based QuantiFERON TB Gold assays with tuberculin skin test in HIV-infected subjects.
    Kabeer BS; Sikhamani R; Raja A
    Diagn Microbiol Infect Dis; 2011 Nov; 71(3):236-43. PubMed ID: 21996360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of interferon-γ and IP-10 for the diagnosis of tuberculosis.
    Holm LL; Rose MV; Kimaro G; Bygbjerg IC; Mfinanga SG; Ravn P; Ruhwald M
    Pediatrics; 2014 Dec; 134(6):e1568-75. PubMed ID: 25422019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of interferon (IFN)-γ inducible protein 10 (IP-10) as a biomarker for the discrimination of active and latent tuberculosis.
    Mamishi S; Mahmoudi S; Banar M; Hosseinpour Sadeghi R; Marjani M; Pourakbari B
    Mol Biol Rep; 2019 Dec; 46(6):6263-6269. PubMed ID: 31564016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.